CADL (STOCKS)
Candel Therapeutics, Inc. Common Stock
$5.530000
-0.230000 (-3.99%)
Prev close: $5.760000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Paul-Peter Tak
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $304.14M
- Employees
- 38
- P/E (TTM)
- -9.89
- P/B (TTM)
- 3.79
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
8
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.21 | $-0.19 | -0.0212 | -11.23% |
|
Jun 2025 (Q2)
|
$-0.09 | $-0.17 | +0.0834 | +48.10% |
|
Mar 2025 (Q1)
|
$0.13 | $-0.31 | +0.4360 | +142.48% |
|
Dec 2024 (Q4)
|
$-0.40 | $-0.23 | -0.1679 | -72.34% |
Financial Statements
| Assets | $93.60M |
| Current Assets | $90.13M |
| Noncurrent Assets | $3.46M |
| Fixed Assets | $1.36M |
| Other Non-current Assets | $2.10M |
| Liabilities | $13.47M |
| Current Liabilities | $10.93M |
| Accounts Payable | $1.12M |
| Wages | $2.57M |
| Other Current Liabilities | $7.24M |
| Noncurrent Liabilities | $2.55M |
| Equity | $80.12M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $80.12M |
| Liabilities And Equity | $93.60M |